Vir Biotechnology (VIR) Cash from Operations (2018 - 2026)

Vir Biotechnology has disclosed Cash from Operations across 9 years of filings, most recently posting 132386000.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 132386000.0, down 69.47% year-over-year; the trailing twelve-month figure through Mar 2026 was 446051000.0 (down 7.46% YoY), and the FY2025 annual result was 391781000.0, up 12.23% from the prior year.
• Cash from Operations came in at 132386000.0 for Q1 2026 at Vir Biotechnology, down from 25876000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 960136000.0 in Q2 2022 to a low of 389247000.0 in Q2 2023.
• The 5-year median for Cash from Operations is 107927000.0 (2023), against an average of 5061823.53.
• Across the five-year window, Cash from Operations jumped 714.43% in 2022 and plunged 407.26% in 2023, its largest moves.
• Vir Biotechnology's Cash from Operations stood at 35126000.0 in 2022, then slumped by 407.26% to 107927000.0 in 2023, then grew by 18.8% to 87635000.0 in 2024, then surged by 70.47% to 25876000.0 in 2025, then tumbled by 411.62% to 132386000.0 in 2026.
• The last three Cash from Operations figures came in at 132386000.0 (Q1 2026), 25876000.0 (Q4 2025), and 167570000.0 (Q3 2025), per Business Quant data.